secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENDRA Life Sciences Inc. (NDRA)
CIK:        0001681682
Form:       8-K
Filed at:   2025-11-14T23:59:59+00:00
Accession:  0001213900-25-110897
Event type: regulatory
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

ENDRA regains Nasdaq equity compliance after $4.9M offering; adds crypto treasury
--------------------------------------------------------------------------------

- Closed Oct 2025 private placement raising ~$4.9M gross via 744,340 shares and warrants.
- Purchased 78,863.1 HYPE tokens on Oct 23, 2025 under new digital asset treasury strategy.
- Entered ATM sales agreement with Lucid Capital Markets for up to $1.75M in common stock.
- Nasdaq granted extension to Nov 24, 2025; company now believes it meets $2.5M equity minimum.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1681682/000121390025110897/0001213900-25-110897-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1681682/000121390025110897/ea0265626-8k_endra.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-110897

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer